July/August 2018
The Journal of Robotics, Artificial Intelligence & Law
By Jessica L.A. Marks; Shana K. Cyr, Ph.D.
Not surprisingly, the nanorobotics industry is growing. As of 2014, there were over 200 companies pursuing commercial efforts in nanomedicine, with at least 23 in the advanced stages of development. The nanorobots market is expected to grow more than six percent each year until at least 2020, with the primary driver being their use in medicine. In this article, Finnegan attorneys Jessica Marks and Shana Cyr discuss government regulation of nanorobots.
Read the full article here.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.